跳至主要内容
临床试验/NCT07119424
NCT07119424招募中不适用

Multidisciplinary Dissection of Renal and Metabolic Effects of Glyfozines on Elderly Patients: From Molecular Aspects to Clinical Indications

Chiara Lanzani1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2025年2月14日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
300
试验地点
1
主要终点
Patient health status prior and after 6 months of SGLT2i therapy through Frailty Index variation (FI)

研究概览

简要总结

The project aims to study the impact of SGLT2i therapy on clinical and biochemical aspects. in elderly. The project will combine different types of data, such as clinical and biological information, and will use advanced Bayesian statistical methods to understand the relationship between risk factors and patient outcomes following treatment with SGLT2 inhibitors.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participant is willing and able to give informed consent for participation in the study;
  • Patients must be enrolled also in MED-Cli e MED-Mol studies by signing both the MED-Cli e MED-Mol informed consents.
  • The medical product is the standard of care for the patient and has been prescribed according to clinical practice and independent of the present study;
  • Age ≥65 years;
  • Participant has not yet started the prescribed SGLT2i therapy;
  • Participant has at least one clinical indication for SGLT2i use according to clinical practice guidelines.

排除标准

  • Current or previous use of SGLT2i;
  • Inability to sign the informed consent.

结局指标

主要结局

Patient health status prior and after 6 months of SGLT2i therapy through Frailty Index variation (FI)

时间窗: From enrollment to 6 months

Patient health status prior and after 6 months of SGLT2i therapy through Frailty Index variation (FI). The FI is score measured by comparing the ratio of health deficits present within an individual to possible health deficits, using a pre-specified list of 30 or more deficits. Deficits included in the model will be collected during the visit trough questionnaires and clinical and biochemical evaluation

次要结局

未报告次要终点

研究者

发起方
Chiara Lanzani
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Chiara Lanzani

Professor

Ospedale San Raffaele

研究点 (1)

Loading locations...

相似试验